Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

8.07
-0.1500-1.82%
Post-market: 8.470.4000+4.96%19:34 EST
Volume:1.05M
Turnover:8.49M
Market Cap:1.11B
PE:-2.11
High:8.31
Open:8.06
Low:7.99
Close:8.22
Loading ...

Vir Biotechnology Inc reports results for the quarter ended in January 1 - Earnings Summary

Reuters
·
01 Nov 2024

U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners -- WSJ

Dow Jones
·
01 Nov 2024

TD Cowen Sticks to Its Buy Rating for Vir Biotechnology (VIR)

TIPRANKS
·
01 Nov 2024

Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
01 Nov 2024

Vir Biotechnology Shares Fall 4.5% After the Bell Following Results

THOMSON REUTERS
·
01 Nov 2024

Vir Biotechnology Q3 2024 Adj EPS $(1.56) Misses $(1.05) Estimate, Sales $2.40M Miss $5.51M Estimate

Benzinga
·
01 Nov 2024

BRIEF-Vir Biotechnology Q3 Cash & Investments USD 1,190 Million

Reuters
·
01 Nov 2024

Vir Biotechnology Inc: Jason O'byrne Appointed as Chief Financial Officer

THOMSON REUTERS
·
01 Nov 2024

Vir Biotechnology Inc Qtrly Net Loss $213.7 Mln, or $1.56 per Share

THOMSON REUTERS
·
01 Nov 2024

Vir Biotechnology Q3 Revenue USD 2.4 Million

THOMSON REUTERS
·
01 Nov 2024

Vir Biotechnology Q3 Cash & Investments USD 1,190 Million

THOMSON REUTERS
·
01 Nov 2024

Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Business Wire
·
01 Nov 2024

Vidrala SA (FRA:VIR) Q3 2024 Earnings Call Highlights: Strong Financial Performance Amidst ...

GuruFocus.com
·
26 Oct 2024

State Street Corp's Strategic Acquisition in Vir Biotechnology Inc

GuruFocus.com
·
19 Oct 2024

BRIEF-VIR Biotechnology To Provide Business Update And Report Third Quarter 2024 Financial Results On October 31, 2024

Reuters
·
18 Oct 2024

Press Release: Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024

Dow Jones
·
18 Oct 2024